Document Detail

Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations.
MedLine Citation:
PMID:  19968966     Owner:  NLM     Status:  MEDLINE    
The heme peroxidase enzyme myeloperoxidase (MPO) is released by activated neutrophils and monocytes, where it uses hydrogen peroxide (H(2)O(2)) to catalyze the production of the potent oxidants hypochlorous acid (HOCl), hypobromous acid (HOBr) and hypothiocyanous acid (HOSCN) from halide and pseudohalide (SCN(-)) ions. These oxidants have been implicated as key mediators of tissue damage in many human inflammatory diseases including atherosclerosis, asthma, rheumatoid arthritis, cystic fibrosis and some cancers. It is shown here that acetaminophen (paracetamol), a phenol-based drug with analgesic and antipyretic actions, is an efficient inhibitor of HOCl and HOBr generation by isolated MPO-H(2)O(2)-halide systems. With physiological halide concentrations, acetaminophen concentrations required for 50% inhibition of oxidant formation (IC(50)) were 77+/-6microM (100mMCl(-)) and 92+/-2microM (100mMCl(-) plus 100microMBr(-)), as measured by trapping of oxidants with taurine. The IC(50) for inhibition of HOCl generation by human neutrophils was ca. 100microM. These values are lower than the maximal therapeutic plasma concentrations of acetaminophen (< or =150microM) resulting from typical dosing regimes. Acetaminophen did not diminish superoxide generation by neutrophils, as measured by lucigenin-dependent chemiluminescence. Inhibition of HOCl production was associated with the generation of fluorescent acetaminophen oxidation products, consistent with acetaminophen acting as a competitive substrate of MPO. Inhibition by acetaminophen was maintained in the presence of heparan sulfate and extracellular matrix, materials implicated in the sequestration of MPO at sites of inflammation in vivo. Overall, these data indicate that acetaminophen may be an important modulator of MPO activity in vivo.
Maud Koelsch; Roger Mallak; Garry G Graham; Tracey Kajer; Marian K Milligan; Ly Q Nguyen; Dawn W Newsham; Jeremy S Keh; Anthony J Kettle; Kieran F Scott; John B Ziegler; David I Pattison; Shanlin Fu; Clare L Hawkins; Martin D Rees; Michael J Davies
Related Documents :
18481016 - Meso-dihydroguaiaretic acid isolated from saururus chinensis inhibits cyclooxygenase-2 ...
20047276 - Antitrypanosomal activity of 1,2-dihydroquinolin-6-ols and their ester derivatives.
14648406 - Cyclized geranyl stilbenes from the rhizomes of helminthostachys zeylanica.
18451566 - Synthesis and hiv-1 integrase inhibition activity of some n-arylindoles.
23015816 - Enantioselective michael addition of 2-hydroxy-1,4-naphthoquinones to nitroalkenes cata...
19406636 - No donors. part 18: bioactive metabolites of gtn and petn--synthesis and vasorelaxant p...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-12-05
Journal Detail:
Title:  Biochemical pharmacology     Volume:  79     ISSN:  1873-2968     ISO Abbreviation:  Biochem. Pharmacol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-02-17     Completed Date:  2010-03-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0101032     Medline TA:  Biochem Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1156-64     Citation Subset:  IM    
Copyright Information:
2009 Elsevier Inc. All rights reserved.
Heart Research Institute, Newtown, Sydney, NSW, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acetaminophen / pharmacology*
Analgesics, Non-Narcotic / pharmacology*
Bromates / metabolism,  toxicity
Hypochlorous Acid / metabolism,  toxicity
Neutrophils / drug effects,  metabolism
Oxidants / metabolism*,  toxicity
Peroxidase / antagonists & inhibitors*
Superoxides / metabolism
Reg. No./Substance:
0/Analgesics, Non-Narcotic; 0/Bromates; 0/Oxidants; 103-90-2/Acetaminophen; 11062-77-4/Superoxides; 13517-11-8/hypobromous acid; 7790-92-3/Hypochlorous Acid; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular en...
Next Document:  Changes in NPY and POMC, but not serotonin transporter, following a restricted feeding/repletion pro...